Jazz Pharmaceuticals expects net proceeds of $1.08B, $1.23B if option exercised
Jazz Pharmaceuticals expects net proceeds of $1.08B from its offering, $1.23B if the option is exercised in full.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.